Senior Director, USMA Oncology

At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.

US Medical Affairs leader for assigned compound under the supervision and leadership of the Executive Director of Medical Research and Strategy, US Oncology Medical Affairs (USOMA). Develops the USOMA strategy and tactical plan as part of the US Brand Strategic Plan and leads the execution of the activities in the USOMA plan including Launch Readiness and Life Cycle Management. Leads the team for this compound.

• Responsible for the development of the USOMA strategy and medical objectives for the assigned compound and leads development and execution of the US Medical Affairs plan and budget management including activities related to evidence generation, scientific engagement and communication as part of Launch Readiness activities and life cycle management from a medical perspective.
• Participates in Global Medical Affairs committees as requested.
• Serves as US Medical Affairs Lead to gain strategic and planning alignment across the matrix team and the core USOMA functions.
• Represents US medical affairs function as a member of cross-functional forums including Publications Planning, Clinical and Safety sub-teams, US and Global Brand Team, and US Product Team to inform clinical development, commercialization, market access, and other cross-functional strategic discussions.
• Provides medical leadership:
• Leads USOMA teams as part of evidence generation forums and study teams for Local/Regional Medical Affairs company sponsored study concepts as needed. Partners with RWE and HEOR strategy and Biomarker/CDx leads on related integrated evidence generation strategies and activities as part of the USOMA Plan. Provides medical review of expanded access programs (EAP) and, investigator-initiated studies (IIS) as part of a US IIS Review Committee, for assigned compound.
• Collaborates with Global Medical Affairs and across USOMA functions to develop, review, and align on key scientific communications and medical information response documents within legal and compliance regulations. Leads internal stakeholder medical education activities related to the compound data. In partnership with Medical Intelligence and Congress Planning leads, communicates and educates on related competitor data.
• Provides medical leadership in scientific engagement activities with key external stakeholders such as advisory boards, investigator interactions, congress activities, peer to peer discussions with key thought leaders. Provides medical support for scientific symposium and medical congresses within legal and compliance regulations.
• Works with Patient Advocacy leads and Grants office to incorporate the patient voice and define external medical education strategies for independent grants, respectively.
• Provides input into publication strategy, data gap analysis, and tactical planning as part of the overall USOMA plan. Reviews and approves abstracts, manuscripts, and other data disclosure documents. Attract and develop USOMA talent. Provides coaching, direction, feedback and guidance as needed. Evaluate team progress against goals/objectives. Manage budgets and resources efficiently for USOMA supported activities within the USOMA plan.
• Experience in collaboration with US Oncology Franchise Head oncology therapeutic area is required.

• Education Qualifications
  An advanced doctorate degree (Pharm
  
  D, PhD, MD, DO or equivalent) in medical/ scientific area required. MD preferred. Experience in oncology therapeutic area required.
• Experience Qualifications
  10 or more years pharmaceutical industry experience or commensurate healthcare or research experience…